Literature DB >> 12193298

Papillary thyroid carcinoma in patients with RET proto-oncogene germline mutation.

Michael Brauckhoff1, Oliver Gimm, Raoul Hinze, Jörg Ukkat, Katrin Brauckhoff, Henning Dralle.   

Abstract

The occurrence of papillary thyroid carcinoma in patients with RET germline mutations has been described in only eight cases since 1993. We report three women with a RET germline mutation in exon 13 and 14, affecting codon 790, 791, and 804, respectively, who underwent prophylactic thyroidectomy at the age of 29, 39, and 24 years, respectively. Histologic examination revealed C-cell hyperplasia and a small medullary thyroid carcinoma in the first patient and no pathologic changes of the C-cells in either of the other patients. However, all patients had papillary thyroid carcinoma (PTC). Concerning the frequency of PTC in patients with RET germline mutations who underwent surgery at our center (n = 104), it was found in 9.1% of all patients with RET mutation in codon 790, 791, and 804 (n = 33) but in none of the 104 patients with RET germline mutations not affecting codon 790, 791, or 804 (p = 0.0015). Our data and the data from the literature suggest a possible pathogenesis of PTC caused by exon 13 and 14 RET mutations that affect the intracellular domain of the encoded protein. Further investigation is necessary to confirm a potential pathogenetic role of exon 13 and 14 RET mutations with regard to the development of PTC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12193298     DOI: 10.1089/105072502320288393

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  23 in total

1.  [Prophylactic thyroid surgery].

Authors:  A Frilling; F Weber
Journal:  Chirurg       Date:  2006-01       Impact factor: 0.955

2.  Papillary thyroid carcinoma and multiple endocrine neoplasia type 2.

Authors:  B Febrero; J M Rodríguez; A Ríos; P Portillo; P Parrilla
Journal:  J Endocrinol Invest       Date:  2015-04-23       Impact factor: 4.256

Review 3.  Synchronous occurrence of medullary and papillary carcinoma of the thyroid in a patient with cutaneous melanoma: determination of BRAFV600E in peripheral blood and tissues. Report of a case and review of the literature.

Authors:  Benedetta Fibbi; Pamela Pinzani; Francesca Salvianti; Matteo Rossi; Luisa Petrone; Maria Laura De Feo; Roberto Panconesi; Vania Vezzosi; Simonetta Bianchi; Gabriele Simontacchi; Monica Mangoni; Maurizio Pertici; Gianni Forti; Cinzia Pupilli
Journal:  Endocr Pathol       Date:  2014-09       Impact factor: 3.943

4.  Case of Concurrent MTC and PTC in a Patient with a Germline RET Mutation.

Authors:  Kinjal Shah; Mohsen Zena; Edward D Adickes; Robert J Anderson
Journal:  Endocr Pathol       Date:  2015-09       Impact factor: 3.943

5.  Synchronous metastatic medullary and papillary thyroid carcinomas in a patient with germline RET mutation: case report, molecular analysis, and implications for pathogenesis.

Authors:  Christopher Griffith; Shengle Zhang; Sanjay Mukhopadhyay
Journal:  Endocr Pathol       Date:  2010-06       Impact factor: 3.943

6.  Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland.

Authors:  R Ciampi; C Romei; L Pieruzzi; A Tacito; E Molinaro; L Agate; V Bottici; F Casella; C Ugolini; G Materazzi; F Basolo; R Elisei
Journal:  J Endocrinol Invest       Date:  2016-08-17       Impact factor: 4.256

7.  Pathogenicity of DNA variants and double mutations in multiple endocrine neoplasia type 2 and von Hippel-Lindau syndrome.

Authors:  Zoran Erlic; Michael M Hoffmann; Maren Sullivan; Gerlind Franke; Mariola Peczkowska; Igor Harsch; Matthias Schott; Helmut E Gabbert; Matti Valimäki; Simon F Preuss; Kornelia Hasse-Lazar; Dariusz Waligorski; Mercedes Robledo; Andrzej Januszewicz; Charis Eng; Hartmut P H Neumann
Journal:  J Clin Endocrinol Metab       Date:  2009-11-11       Impact factor: 5.958

Review 8.  On the Origin of Cells and Derivation of Thyroid Cancer: C Cell Story Revisited.

Authors:  Mikael Nilsson; Dillwyn Williams
Journal:  Eur Thyroid J       Date:  2016-06-24

9.  Codon Y791F mutations in a large kindred: is prophylactic thyroidectomy always indicated?

Authors:  Peter Vestergaard; Else Marie Vestergaard; Helle Brockstedt; Peer Christiansen
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

Review 10.  Metachronous appearance of second malignancies in medullary thyroid carcinoma (MTC) patients: a diagnostic challenge and brief review of the literature.

Authors:  Maria Alevizaki; Elena Kyratzoglou; Aristoteles Bamias; Marinella Tzanela; Meletios A Dimopoulos; Katerina Saltiki
Journal:  Endocrine       Date:  2013-04-23       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.